The extent of CA in HCT116 cells was comparable to that of low-dose–treated prostate cancer cells (14, 21) and similar to an ectopic expression of PLK4, the master regulatory kinase of centrosome duplication ((37), Fig S1E), suggesting that basically all cells respond to the treatment. Here, PLK4 is linked to prostate carcinoma.